The Prevalence, Impact and Economic Implications of Atrial Fibrillation in Stroke: What Progress Has Been Made?

Atrial fibrillation (AF) is a major risk factor for stroke, especially in the elderly. Increased life expectancies mean that AF-related stroke is a growing global public health concern. Improvements in the detection, treatment and prevention of the consequences of AF have occurred in recent years. However, the extent to which these improvements have impacted on the prevalence of AF, the risk of AF-related stroke and subsequent economic costs are unknown. This review provides a contemporary assessment of the epidemiological data on AF-related stroke aimed at assessing the effectiveness of primary prevention strategies and associated economic implications with reductions in stroke incidence. A systematic review of the literature was performed. Appropriately designed studies were identified and retrieved. Evidence on changes in the prevalence of AF, the risk of stroke associated with AF and the excess cost of AF-related stroke over the last 30 years was summarised. The results provide evidence that the age-adjusted prevalence of AF and the relative risk of stroke associated with AF has remained relatively constant. Unless action is taken to improve detection of AF and reduce its consequences, a considerable increase in the social and economic burden associated with AF-related stroke is likely.

[1]  T. Dawber,et al.  The Framingham Study , 2014 .

[2]  Wei Chen,et al.  HOW FAST IS THE POPULATION AGEING IN CHINA? , 2013 .

[3]  C. Yeh,et al.  Underuse of Antithrombotic Therapy Caused High Incidence of Ischemic Stroke in Patients with Atrial Fibrillation , 2012, International journal of stroke : official journal of the International Stroke Society.

[4]  M. Kaste,et al.  Direct Costs of Patients With Stroke Can Be Continuously Monitored on a National Level: Performance, Effectiveness, and Costs of Treatment Episodes in Stroke (PERFECT Stroke) Database in Finland , 2011, Stroke.

[5]  R. Sandhu,et al.  The epidemiology of atrial fibrillation in adults depends on locale of diagnosis. , 2011, American heart journal.

[6]  S. Connolly,et al.  Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: A Canadian payer perspective , 2011, Thrombosis and Haemostasis.

[7]  R. P. Zhu,et al.  Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial Fibrillation , 2011, Annals of Internal Medicine.

[8]  B. Gage,et al.  Abstract 16179: Cost-effectiveness of Dabigatran for Stroke Prophylaxis in Atrial Fibrillation , 2010 .

[9]  P. Barber,et al.  Pathophysiological Determinants of Worse Stroke Outcome in Atrial Fibrillation , 2010, Cerebrovascular Diseases.

[10]  M. Costanza,et al.  Low prevalence of atrial fibrillation in asymptomatic adults in Geneva, Switzerland. , 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[11]  K. Chien,et al.  Atrial fibrillation prevalence, incidence and risk of stroke and all-cause death among Chinese. , 2010, International journal of cardiology.

[12]  M. Mendes,et al.  Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. , 2010, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[13]  S. Iliceto,et al.  Prevalence, functional impact, and mortality of atrial fibrillation in an older Italian population (from the Pro.V.A. study). , 2009, The American journal of cardiology.

[14]  Y. Friedlander,et al.  A comparison of risk factors for coronary heart disease and ischaemic stroke: the Dubbo study of Australian elderly. , 2009, Heart, lung & circulation.

[15]  W. Baker,et al.  Meta-Analysis to Assess the Quality of Warfarin Control in Atrial Fibrillation Patients in the United States , 2009, Journal of managed care pharmacy : JMCP.

[16]  D. Levy,et al.  Prevention of Atrial Fibrillation: Report From a National Heart, Lung, and Blood Institute Workshop , 2009, Circulation.

[17]  D. Hu,et al.  An Epidemiological Study on the Prevalence of Atrial Fibrillation in the Chinese Population of Mainland China , 2008, Journal of epidemiology.

[18]  E. Glader,et al.  The effect of atrial fibrillation on stroke-related inpatient costs in Sweden: a 3-year analysis of registry incidence data from 2001. , 2008, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[19]  Emma Heeley,et al.  Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme. , 2008, American heart journal.

[20]  K. Kimura,et al.  Prevalence of atrial fibrillation in community-dwelling Japanese aged 40 years or older in Japan: analysis of 41,436 non-employee residents in Kurashiki-city. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[21]  T. Ng,et al.  Low prevalence of atrial fibrillation in community-dwelling Chinese aged 55 years or older in Singapore: a population-based study. , 2008, Journal of electrocardiology.

[22]  Luis Alberto García Rodríguez,et al.  Risk of Cerebrovascular Accident After a First Diagnosis of Atrial Fibrillation , 2007, Clinical cardiology.

[23]  G. Lip,et al.  Atrial fibrillation and stroke prevention , 2007, The Lancet Neurology.

[24]  E. Elm,et al.  The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, The Lancet.

[25]  S. Pocock,et al.  Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies , 2007, BMJ : British Medical Journal.

[26]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, Annals of Internal Medicine [serial online].

[27]  M. Aguilar,et al.  Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation , 2007, Annals of Internal Medicine.

[28]  P. Macfarlane,et al.  The Routine Electrocardiogram for Cardiovascular Risk Stratification in Old Age: The Leiden 85‐Plus Study , 2007, Journal of the American Geriatrics Society.

[29]  J. Cox,et al.  The impact of warfarin use on clinical outcomes in atrial fibrillation: a population-based study. , 2007, The Canadian journal of cardiology.

[30]  S. Willich,et al.  The impact of atrial fibrillation on the cost of stroke: the berlin acute stroke study. , 2007, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[31]  Colin Simpson,et al.  A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland , 2007, Heart.

[32]  S. Willich,et al.  Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice , 2007, Journal of Thrombosis and Thrombolysis.

[33]  A. Hofman,et al.  Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. , 2006, European heart journal.

[34]  S. Finfer.  SAFE (The Saline versus Albumin Fluid Evaluation) 試験 , 2006 .

[35]  D. Cook,et al.  Trends in the prevalence of diagnosed atrial fibrillation, its treatment with anticoagulation and predictors of such treatment in UK primary care , 2005, Heart.

[36]  D. Fitzmaurice,et al.  A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. , 2005, Health technology assessment.

[37]  P. Vestergaard,et al.  Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. , 2005, International journal of cardiology.

[38]  L. Parnetti,et al.  Atrial fibrillation in patients with first‐ever stroke: frequency, antithrombotic treatment before the event and effect on clinical outcome , 2005, Journal of thrombosis and haemostasis : JTH.

[39]  Robert Safford,et al.  Asymptomatic atrial fibrillation: demographic features and prognostic information from the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. , 2005, American heart journal.

[40]  C Fraser,et al.  Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation. , 2005, Health technology assessment.

[41]  T. Truelsen,et al.  Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study). , 2004, The American journal of cardiology.

[42]  Theodor Landis,et al.  Usefulness of Ambulatory 7-Day ECG Monitoring for the Detection of Atrial Fibrillation and Flutter After Acute Stroke and Transient Ischemic Attack , 2004, Stroke.

[43]  A. Go,et al.  Racial variation in the prevalence of atrial fibrillation among patients with heart failure: the Epidemiology, Practice, Outcomes, and Costs of Heart Failure (EPOCH) study. , 2004, Journal of the American College of Cardiology.

[44]  G. Jensen,et al.  Sex-specific increase in the prevalence of atrial fibrillation (The Copenhagen City Heart Study). , 2003, The American journal of cardiology.

[45]  Pierre Côté,et al.  Loss to Follow-Up in Cohort Studies: How Much is Too Much? , 2003, European Journal of Epidemiology.

[46]  Simon Stewart,et al.  A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. , 2002, The American journal of medicine.

[47]  H. Uphoff,et al.  Heterogeneous case definitions used for the surveillance of influenza in Europe , 2002, European Journal of Epidemiology.

[48]  C. Wolfe,et al.  Characteristics, Outcome, and Care of Stroke Associated With Atrial Fibrillation in Europe: Data From a Multicenter Multinational Hospital–Based Registry (The European Community Stroke Project) , 2001, Stroke.

[49]  Z. Yuan,et al.  Risk of stroke in patients with atrial flutter. , 2001, The American journal of cardiology.

[50]  A. John Camm,et al.  Clinical Relevance of Silent Atrial Fibrillation: Prevalence, Prognosis, Quality of Life, and Management , 2000, Journal of Interventional Cardiac Electrophysiology.

[51]  A. Arboix,et al.  Atrial fibrillation and stroke: clinical presentation of cardioembolic versus atherothrombotic infarction. , 2000, International journal of cardiology.

[52]  P A Wolf,et al.  Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. , 1998, The American journal of cardiology.

[53]  C. Sudlow,et al.  Comparable studies of the incidence of stroke and its pathological types: results from an international collaboration. International Stroke Incidence Collaboration. , 1997, Stroke.

[54]  R B D'Agostino,et al.  Stroke severity in atrial fibrillation. The Framingham Study. , 1996, Stroke.

[55]  R B D'Agostino,et al.  Secular trends in the prevalence of atrial fibrillation: The Framingham Study. , 1996, American heart journal.

[56]  J. Gardin,et al.  Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). , 1994, The American journal of cardiology.

[57]  P. Wolf,et al.  Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. , 1991, Stroke.

[58]  D L Rosman,et al.  Atrial fibrillation and mortality in an elderly population. , 1989, Australian and New Zealand journal of medicine.

[59]  P. T. Onundarson,et al.  Chronic atrial fibrillation--epidemiologic features and 14 year follow-up: a case control study. , 1987, European heart journal.

[60]  D L McGee,et al.  Duration of atrial fibrillation and imminence of stroke: the Framingham study. , 1983, Stroke.

[61]  A. Camm,et al.  The rhythm of the heart in active elderly subjects. , 1980, American heart journal.

[62]  A. Waldo,et al.  Chronic atrial fibrillation: Incidence, prevalence, and prediction of stroke using the Congestive heart failure, Hypertension, Age >75, Diabetes mellitus, and prior Stroke or transient ischemic attack (CHADS2) risk stratification scheme , 2009 .

[63]  E. Benjamin,et al.  Status of the epidemiology of atrial fibrillation. , 2008, The Medical clinics of North America.

[64]  S. Bansil,et al.  Detection of atrial fibrillation in patients with acute stroke. , 2004, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.